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NON-SPECIFIC PROTEIN THERAPY IN ASTHMA
AND RHEUMATOID ARTHRITIS.
In the general acceptance of the term - "non¬
specific protein therapy" - any attempt to treat
disease by means of a protein is included, except
the use of specific vaccines made from the organisms
that are causing the complaint, and the use of minute
doses of the proteins to which the patient is sensi¬
tive. in the practice of non-specific therapy a
large number-of therapeutic agents have been used
varying from the ancient forms of counter irritation
to out present methods of heterobacteriotherapy, of
protein therapy, and of the Intravenous injections of
colloidal metals or other colloid substances.
Here we shall deal chiefly with "Peptone" in
the treatment of Asthma and Rheumatoid Arthritis.
Peptone is not a protein but a protein derivative.
The value of treatment by peptone has been ascribed
to the proteoses and albumoses which some forms of
it contain, and these protein derivatives form a
stage between the whole native protein and the more
fully hydrolysed peptone.
Two varieties of Peptone were used.-
(1) Armour's/
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(1) Armour's Peptone - 20fo sol. or 1 cc. = .2 gms.
It was given by intramuscular injections
into buttock.
(2) Witte's Peptone - 2% - 5% sol. It was given
intravenously•
Peptone when given in small doses, especially intra¬
muscularly, produced no untoward effect, but when
given in larger doses, intramuscularly or intra¬
venously, produced a violent Reaction, termed
"Protein Shock". In the treatment of Rheumatoid
Arthritis this "Protein Shock" was of paramount im¬
portance, whereas in the treatment of Asthma it was
of much less importance. Patients may be peculiarly
sensitive to Peptone, so it was essential in all the
cases, prior to treatment, to determine by the dermal
reaction whether or not the patients were sensitive.
ThQ treatment of these two diseases by Peptone




Twenty oases were treated with Peptone.
It is well known that Asthmatics are very
often sensitive to a foreign protein which may be
the actual cause of the Asthma. As a matter of
interest the "cutaneous reactions" were done in
these cases to find out the nature of the foreign
protein to which the patient might react, whether
food, bacteria, feathers, hairs, or pollens. In
treatment by non-specific therapy these reactions
were of little importance, but it might be of interest
to note that 12 of the patients were sensitive to
one or more of the Cereals, 6 to Hairs and Pollens,
and S to Bacteria.
The three chief ways of treating Asthma by
Peptone are.-
(1) By single intravenous injections of large doses
producing "Protein Shock".
(2) By the intravenous or intramuscular injections
of smaller doses.
(3) By oral administration.




1. In 15 of the oases Armour's Peptone was used -
20% sol., intramuscular injections into buttock.
Initial dose .2 gms.j 2nd dose .3 gms. given
4 days laterj and then succeeding doses at intervals
of 6 - 7 days, gradually increasing the dose by
• 1 gm.
2. Witte's Peptone in 5. cases - 2% sol. given
intravenously.
Initial dose 5 min., gradually increasing by
2^- min., at intervals of 6 - 7 days.
STUDY OF OASES TREATED.
Ages of the patients ranged between IS yrs. and
55 yrs. In about 75% of these cases there was a
definite family history of Asthma.-
8 of the cases were of the clean spasmodic type,
whereas the other 12 were complicated with permanent
bronchitis and emphysema.
The results of the treatment varied in the
different cases. There were four types of cases.-
(1)/
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(1) Those who were soon cured by Peptone.
(2) Those who improved slowly.
(3) Those who were apparently cured but relapsed,
further injections being necessary.
(4) Those in whom the Peptone met with little success.
1. Those soon cured - 5 Cases.
In this type of case improvement occurred
after the first few injections. This was where the
Asthma was uncomplicated with any bronchitis or
emphysema.
Oase 1. Man aged 28 yrs. Duration of Asthma
3 years. Definite family history. By cut¬
aneous reactions sensitive to horse hair
and oats. Woke up at nights with typical attacks,
great difficulty in breathing etc. Had these attacks
all the year round, one almost every two or three
weeks. He had an attack just before treatment began.
Began Peptone (1) Initial Dose .8 gms.
(2) .3 gms. 4 days later, (3) .4 gms. 6 days later,
(4) .5 gms. 7 days later. No further injections give|n.
He had no more attacks. Was seen 5 months later and
had had no further attacks.
6.
Case 8. Male aged 54 years. Duration of Asthma
5 years. Sensitive to foreign proteins -
wheat, rice. Family history.
Peptone begun - Initial dose 5 min. of a Q.% sol.
Witte's Peptone. A definite "Protein Shook" was
accidentally produced. Patient felt very ill, rest¬
less, cough exceedingly troublesome, marked dyspnoea,
headache, temperature 102°• Within 24 hours these
symptoms had disappeared and patient felt distinctly
improved. He had no further attacks of Asthma.
Seen 8 weeks later and had been free from attacks.
There was a third case of this type cured -
treated by intramuscular injections, 4 injections
being necessary.
In these three cases the Asthma had only been of
a few years' duration, the longest being 5 years, and
they were not complicated with any bronchitis or
emphysema.
2. Those who improved slowly - 8 Oases.
They were of longer duration than the first
type, all of them - except 1 - being over 5 years*
duration.
They/
They were all treated with Armour's Peptone
intramuscularly. The dosage in all of them had
gradually to be increased until a slight reaction or
slight "protein shock" was produced, before any
improvement was noticed. Some authorities advocate
that in the treatment of Asthma with Peptone the best
results are obtained by producing a definite "Protein
Shock". The intravenous case described in the last
group rather supports this view.
Case 1. Male aged 40 years. Had typical asthmatic
attacks occurring at short intervals. Also
evidence of bronchitis and emphysema.
Duration of asthma 10 years. Family history.
Armour's Peptone begun. Initial dose ,2 gms.
and gradually increased each week until 8 injections
had been given, .g gms. being reached. Patient had
slight attack of asthma a few days after 1st injec-
i
tion. After the 8th injection, patient began to
o
complain of headache, nausea, Temp. 99.4 , Pulse 100,
feeling out of sorts, cough became much worse and
sputum more copious. After this slight "protein
shock". No further injections were necessary.




The other 7 oases were of a similar nature to
that described, and in all of them the Peptone had
to be pushed before any beneficial effects were
noticed. The course was therefore much more prolonged,
0-8 injections being necessary. The nature of
"Protein Shock" will be described fully when dealing
with Rheumatoid Arthritis.
3. Those apparently oured but relapsed, further
injections being necessary - 5 Oases.
2 were treated with Armour's Peptone.
3 " " " Witte's "
Case 1. Female, aged 33 years. Had Asthma for 12
years. Occurring during winter every fort¬
night, at other times once every month or so.
Cutaneous reactions - sensitive to B. proteus, milk,
wheat.
Treatment by Armour's Peptone in usual way.
After 4 injections had no further attaoks until 2
months later— she had first a slight attack followed
a week later by a definite asthmatic attack. Course
recommenced and a full course of 8 injections were
given - .8 gms. being reached - For 10 weeks she has
had no further attacks.
Case g./
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Case 2. Male, aged 35 years. Definite asthmatic
attacks complicated with permanent bronchiti8
Duration of asthma 14 years.
Treated with Witte's Peptone intravenously. Initial
dose 5 min. of a 2% sol. - increased gradually until
a reaction produced. A fortnight later he had anothe
asthmatic attack. Peptone again started, and several
more injections given. Peptone was then stopped.
He had had no further attacks when seen 2 months later
The intravenous cases in this group showed
(1) that the reaction was more violent than that seen
in intramuscular oases,
(S) there was a greater tendency for the Asthma when
treated with Peptone intravenously to recur, a fur¬
ther course or courses of Peptone being necessary.
The recurrence always occurred within 2-6 weeks
after the apparent cure. In one case three separate
courses of Peptone were required.
4. Those who met with little success - 4 cases.
In these cases the Asthma was long standing,
in three of them since early adult life. The duration
ranged from 22 years to 49 years. Furthermore they




Peptone-Therapy was first tried alone, in 1 case
intravenously and in the other £ cases intramuscularly
The doses were gradually increased until a reaction wa
produced. It must he admitted that the peptone met
with little success. The severity of the attacks was
diminished if anything, but the number in most cases
was not reduced. A course of autogenous vaccine was
then given in each case, followed sometimes by another
course of Peptone. In all of the cases no Improve¬
ment occurred except in one, when the patient was
temporarily free from Asthma for 2 months during the
course of the vaccine.
As an example of the autogenous vaccine prepared
in one case:-
1 cc. approx. contains
Strept. 100 millions
Staphyl. 500 tt
Initial dose .1 cc. gradually increasing by .1 cc.
weekly, provided no reaction produced by previous
dose.
One course of injections = 6-8 injections.
In one of these cases another non-specific
protein was used - where peptone had failed and also
the autogenous vaccine. This was a mixed coliform
vaccine/
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vaccine prepared from the patient's intestinal flora.
Such a vaccine contained Strept. faecalis, B. coli
and B. proteus. The initial dose contained one
million of each* A course was tried, but failed
like the others.
In passing one interesting point might be noted.
It is asserted by some authorities that specific
vaccine therapy in Asthma is not only useless but
harmful in a great number of cases. This is explained
by assuming that the patient may be sensitive to some
of the catarrhal microbes, and an injection of the
specific organism or organisms to which the patient
is sensitive may produce an anaphylactic reaction.
In these cases no such reaction was observed after
any injection of the specific vaccine.
ACTION OF PEPTONE IN ASTHMA.
Exactly how Peptone worked in curing or improving
Asthma was difficult to say. Two explanations might
be put forward. (1) It effected the cure of the
patient by a mechanism in a way similar to that of the
"shock method", or (2) by a process of desensitisation
or neutralisation.
The latter explanation is most usually accepted.
In the blood of these patients sensitive to a partic¬
ular foreign protein or proteins a substance is f
12.
la supposed to exist which has been termed a specific
adzyme. This has the power of interaction with more
of the specific foreign protein to which the patient
is sensitive, that chances to gain further entrance
to the body. The interaction between the specific
adzyme and its protein substrate causes an anaphy¬
lactic phenomenon, namely Asthma. Injections of
proteins other than the specific protein to which the
patient is sensitive must be dealt with in some way
by the patient. The process of dealing with this
new protein causes the specific adzyme to become so
altered that it may have no specific action left.
This process whereby the specific adzyme becomes
desensitised will result beneficially in curing the
patient of asthma.
One cannot be too dogmatic in asserting that
Peptone acts by a process of desensitisation. In a
great many cases of Asthma the malady may depart when
the patient suffers from a temperature due to some
infectious complaint, and remains away for a certain
period after the fever abates. In having to fight
this infection his specific adzyme has become de¬
sensitised for the time being, or alternatively we




Does the value of Peptone in Asthma lie In
"Protein Shook" or not? In the cases which cleared
up after the first few doses of Peptone this process
of desensitisation can be readily understood. On the
other hand as was seen in the majority of the cases
studied, a degree of "Protein Shock" had to be induced
before any improvement occurred. It would therefore
appear that the improvement was either due to a
gradual process of desensitisation, or that "Protein
Shock" alone caused the improvement as was borne out
by the cure resulting from a single intravenous dose
of Peptone. It will be seen later that the mechanisir
of "Protein Shock" may be a process of desensitisatior
or neutralisation also. Is there any relationship
between the process of desensitisation already des¬
cribed in Asthma, and the process of desensitisation
that is supposed to occur in "Protein Shock"?
14.
TREATMENT OF "RHEUMATOID ARTHRITIS"
WITH PEPTONE.
The term "Rheumatoid Arthritis" includes
Rheumatoid Arthritis Proper and Osteo-Arthritis.
A study of 25 cases was made, 1£ being cases of
Rheumatoid Arthritis Proper and 7 being cases of
Osteo-Arthritis.
Mention will also be made of a case of Subacute
Arthritis treated with Peptone.
METHOD OF TREATMENT.
As in Asthma most of the cases were treated with
Armour's Peptone intramuscularly, E only were treated
with Witte's Peptone intravenously.
(1) Armour's Peptone - 20$ sol.
Initial dose .5 gms.,gradually increasing the
dose weekly by .1 gm. or .2 gms. until a very violent
reaction or "Protein Shock" was induced.
(2) Witte's Peptone - 5$ sol. used.
Initial dose .1 cc., gradually increasing until
"Protein Shock" induced.
As in cases of Asthma a cutaneous reaction was
done prior to the commencement of the treatment
determining whether or not the patient was sensitive




Th© value of Peptone Therapy in Rheumatoid
Arthritis lay in the production of the "Protein Shock".
What is "Protein Shock"? By it is meant the reaction
produced in a "diseased" individual after an injection
of Peptone. This reaction may be subdivided into a
General and a Focal Reaction. The reaction varied
with the dosage used, with the method of application
whether intramuscularly or intravenously, with the'
number of previous injections, with the physical con¬
dition of the patient, with the duration of the dis¬
ease from which the patient was suffering, with the
temperature of the patient at the time of the injec¬
tion and other individual factors. The reaction
varied from a mere febrile reaction to an extreme
shock picture. The dosage used for the production
of "Protein Shock" varied in the different cases, and
will be seen in the study of the cases made later.
With the intravenous injection the reaction was
usually more intense. Before a study of the cases
is made the two reactions, General and Focal, occur¬




The evidence of the General Reaction included
(1) the Chill, (2) Fever, (3) Sweat, (4) Rapid Pulse,
(5) Nausea and Vomiting, (8) Headache, (7) Nervous
Irritability, (8) Leucocytosis.
1. The first symptom of the "Protein Shock" was
usually a rigor or shivering. This usually get
in from hr - 2 hrs. after the injection. The degree'
of reaction varied. In a mild case of "Protein Shock"
it was not noticed, but wherever the shock was at all
moderately severe it was observed without fail.
It passed off in a few minutes.
2. The Temperature.
In all of the cases this was the prominent and
constant feature, the change in the Temperature Curve,
With the subsidence of the Chill, the Temperature of
the Patient usually commenced to rise. In some cases
of mild reactions it would rise 1° - 2° F., but in
most cases where moderate reactions were produced it
would reach 102° - 103°. In one case of a violent
reaction it reached 103.8°• Within 9-12 hours
after the injection the maximum temperature was
reached, which gradually fell by lysis and reached





ion in GREEN. Temperature in BLACK.Pulse in RED. R
BOWELS
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depended to a large degree on the individual as well
as the dosage. (See Temperature Charts.)
3. Pulse and Blood Pressure.
Coincident with the Temperature Reaction the
frequency of the Pulse was increased. The increase ir.
frequency varied from 25 - 45 per minute. The quality
of the Pulse was not altered, and in no case was any
arrhythmia noticed.
In a few of the cases the Blood Pressure was
taken at the height of the Fever and after the Fever
had subsided* When the Fever was at its height the
Blood Pressure was found to he increased by about
5-10 mm., whereas after it "had subsided the Blood
Pressure had returned to normal.
4. Sweating.
This was found in about 75$ of the cases occurring
after the rigor and when the Temperature commenced
to rise.
5. Nausea and Vomiting.
Only present in 2 cases.
6. Headache.
Observed in most of the cases and was worst at




In each of the cases a white blood count was done
and also a blood film made for a differential count.
Two sets of observations were made. In one set com¬
prising 18_ cases a leucocytosis was noted beginning
shortly after the injection and persisting for 2-3
days (after it). The average leucocytosis was
15 - 20,000 leucocytes. In the other set comprising
the remaining 9_ cases a leucopaenia was observed
during the fever, and then a leucocytosis - varying
from 15 - 30,000 - commenced, when the fever was
abating and continued for 3-4 days.
A differential count showed that in all of the
cases the increase in leucocytes was a polymorph one,
both relative and absolute. The other cells were
more or less normal in numbers. The films showed
no abnormal cells.
8. Nervous Irritability.
Th© patient was usually exceedingly irritable afte
the injections, and more sensitive to pain.
9. Urine.
Examination of the urine in all the cases revealec.




10. Weight of Patient.
No change in weight waa noted during the course
of injections.
FOCAL REACTION.
Just as there was a General Reaction after an
injection of Peptone, so it was observed that the
affected joints became very much inflamed. There
was an increase of pain, tenderness, and hyperaemia.
This Focal Reaction - as it is called - was of a
Diphasic Character. The first phase was the
Negative Phase when the evidences of inflammation
were increased - pain and swelling augmented and the
function of the joints impaired. This phase lasted
all through and after the Fever Stage, on an average
about 24-48 hours. This wa3 followed by a Positive
Phase during which there was a progressive diminution
of the inflammation, until the "pre-injection stage"
was reached or more often passed because in the
majority of the cases treated the joints became less
painful and more mobile than they had hitherto been.
This Positive Phase might be called the "curative
stage". Therefore in treatment we should like to
make the Negative or Inflammatory Phase as short as
possible, and the Positive Phase relatively intense
and/
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and protracted. But it was proved from a study of
these cases that the degree and extent of the
"Positive Phase" was closely dependent and correlated
with the Negative Phase.
MECHANISM OP THE REACTION.
The evidence of the reaction of the patient -
the chill, fever, sweat and leucocytoeis - might all
be assumed to have some bearing on the therapeutic
result. We know from experience that a thorough
sweat frequently cuts short and relieves the symptom¬
atology of many diseases, and also that an intercurrer
febrile course often favourably influences a pre¬
existing disease process. But none of these observabi
reactions seemed sufficient to account for the
striking effect that occasionally followed these
injections of Peptone. Many theories have been put
forward, but only the two most important will be
mentioned.
The first theory supposes that this reaction
stimulates all the cells of the organism to greater
activity in the production of either specific sub¬
stances, anti-bacterial in character, or merely in¬
creases the General Reaction to intoxication by
speeding/
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speeding up the mechanism of detoxicatlon.
The second theory is the one more generally
accepted. The blood of a normal person has various
proteolytic enzymes and antiferments. It contains an
enzyme, proteose, which has the power of breaking down
the larger peptone fragments to smaller and non-toxic
amino-acids. The antiferment is a substance which
neutralises or rather stops the actions of these
ferments. During the intoxication which results from
bacterial infection, either acute or chronic and the
general stagnation of cell activity that takes place,
these enzymes become increasingly inactive with the
result that split-protein poisons are circulating
through the blood. With the production of "protein
shock" these enzymes become greatly increased and
activated so that the split-protein poisons are
quickly hydrolysed and removed from the circulation.
At present there are many other theories besides
the above put forward to explain the beneficial
effects of "Protein Shock".
STUDY OF THE GASES.
Now that "Protein Shock" has been described let
us make a study of the cases treated. They will be
divided/
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divided into two main groups.-
(1) Rheumatoid Arthritis Proper - 18 oases.
(2) Osteo-Arthritis - 7 cases.
Such a division is necessary, because the results
were so different in the two groups.
Befere taking up these two groups a case of
Subacute Arthritis treated and cured with Peptone will
be described.
Case. Female, aged 34 years. History of 4 previous
attacks of acute rheumatism. Joints involved
were those of both wrists and the metacarpo¬
phalangeal of both handsj Temp, varying from 99° -
100°. The case was treated for 3 weeks with salicy¬
lates, but the temperature did not fall for any length
of time and the joints remained more or less in the
same painful condition.
Armour's Peptone begun. Initial dose .3 gms.,
gradually increased. After the 3rd dose, .5 gms, a
reaction was induced. Th© joints cleared up, the
temperature fell to normal, and the pain quickly
disappeared from the joints.
1* Rheumatoid Arthritis Proper.
Of the 18 cases belonging to this group,
(a)/
23.
(a) 2 were cured.
(b) j3 were markedly improved.
(c) 8 were slightly improved.
(d) 2 were not benefited.
(a) By the term "cured" was meant that the joints
became free from pain, and their mobility re¬
turned almost to normal.
The 2 cases cured included male and 1 female.
In both cases the sites of the rheumatoid arthritis
were the metacarpo-phalangeal joints and the phalan¬
geal joints of both hands. The affected joints
showed swelling, signs of effusion. There was pain
on movement and limitation of the movements.
Armour's Peptone begun. Initial dose .5 gms.
In the case of the female 2 doses were given, and
with the 2nd dose a definite shock was induced.
In the case of the male 4 doses were required before
a reaction took place. Immediately after the re¬
action the positive phase set in with gradual im¬
provement until within 2-3 days both patients were
free from pain and able to move the joints freely.
These cases were kept under observation from 8 - 10
weeks, and there was no recurrence.
(b) Markedly improved - 6 cases.
By this was meant that the affected joints were
practically/
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practically free from pain, but that the normal move¬
ments were not fully restored. All these cases were
of longer duration than those of the first group, and
definite changes of deformity had occurred in the
joints. There were signs of definite wasting in the
muscles around the affected joints, changes in the
bones themselves, and also some trophic changes in
the skin over these joints.
Case 1. This was a case of the mono-articular variet
following injury.
Man aged 40 years. Injury to shoulder
joint 1 year previous without any fracture or dis¬
location of the bones. Since then the joint had
become painful, and the movements exceedingly limited
X-rays showed rheumatoid changes in the joint with
probable adhesions. There was distinct limitation of
the abduction and rotation movements, and to a less
extent of flexion and extension.
Armour's Peptone begun. Initial dose .5 gms.
After each dose, although no definite shock was in¬
duced, there was distinct improvement in the movements
of the joint. With the 5th dose there was a violent
reaction, temp. 103°, and the joint became extremely
inflamed, tender, swollen and painful, the patient
being unable to get a sleep that night. Then follow¬
ed the Positive Phase with the marked improvement.
Within/
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Within 48 hours the movements gradually improved, and
the joint was practically free from pain.
The only movements which remained slightly limited
were abduction and rotation. Patient was discharged
iS weeks later, and on enquiry 55 months afterwards
there had been no relapse and the patient was able to
follow out his occupation of a Railway Guard.
The other cases were of the whand-and-wrist
variety", and showed marked improvement under treat¬
ment. There were no recurrences in any of the cases.
(c) Slightly improved - 8 cases.
By this was meant that the pain in the affected
joints became less marked, but distinct limitation
of movements remained* In these cases the deformity
of the joint was more marked - they were more advanced,
cases.
It must be admitted that one case belonged to
this section where the deformities were slight, and
where the disease appeared to be in the earliest stage,
yet it resisted all efforts to Peptone Therapy, and
the success was practically nil.
To this group belonged a few cases in which there
were slight osteo-arthritic changes, but not marked
enough to be classified in the osteo-arthritic group.
The/
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The doses of Peptone were increased gradually in
all of these cases until a definite reaction was
I
produced. The joints certainly passed through a
Negative Phase hut the Positive Phase was short.
Recurrences occurred in 55 of the cases in 2 - 4 weeks
after th© slight improvement - when Peptone was again
begun, and "pushed" without success.
(d) No improvement - 2 cases.
There were 2_ cases which showed no improvement.
They remained as painful and as "stiff" as they had
been before the commencement of the treatment. These
cases were more advanced, and of longer duration than
any of the others mentioned.
2. 0step-arthritic Group - 7 cases.
(a) Cured - none.
(b) Markedly improved - 1 case.
(c) Slightly improved - 4 cases.
(d) No improvement - 2 cases.
It will be seen that Peptone Therapy in this group
met with little success. Bony changes had occurred,
lipping of the bones and marked deformity of the





There were 2 vertebral cases, _1 cervical and _1 lumbar.
Both of them showed no improvement under Peptone.
1. Oervical Case.
Man .aged 57 years. Stiffness of neck of
13 years duration. Definite osteo-arthritic changes
in lower cervical vertebrae as seen by X-rays.
Unable to flex or rotate neck. Armour's Peptone -
@ injections given and although "protein shock" pro¬
duced, it had no beneficial effect whatever.
2. Lumbar Case.
Man aged 38 years. Sciatica left leg -
duration 2 years. Osteo-arthritic changes in lumbar
vertebrae as shown in X-rays. Witte's Peptone given
intravenously - 5% sol. "Protein Shock" produced with
no good result.
Hip-Joint Oases.
Mono-articular variety of osteo-arthritis -
5 cases. All of them shov/ed slight improvement with
Peptone. There was less pain and increased mobility
in the joint. Armour's Peptone used in 2 cases and




1^ case - Mono-articular osteo-arthritis in
right knee following injury. Slight improvement with
Witte's Peptone.
Hand.
JL case - Wrist and fingers of "both hands in¬
volved. Markedly improved. Armour's Peptone given ■
after 4 injections reaction produced. Thereafter
improvement set in with increased mobility and lessened
pain in the affected joints. There was no recurrence
in the joints after 8 weeks.
ACTION OF PEPTONE IN RHEUMATOID ARTHRITIS.
The mechanism that is involved in the recovery
of the patient is still quite obscure. We have seen
that an injection of Peptone causing "Protein Shock"
brings about a General and a Focal Reaction, and
that the mechanism of recovery hinges on this "reactio
As a result of this "reaction" the local tissues in
the affected joints may become immune to the toxic




it may mean a "neutralisation or hydrolysation of
split-protein poisons" present in the.circulation and
to which the local tissues have heretofore been
sensitive. The latter explanation is the more pro¬
bable, and as it has been studied in detail under




In summing up the results of Peptone Therapy
in the 20 cases of Asthma:-
1. On the whole the results were good.
2. That the pure spasmodic case uncomplicated by
bronchitis repsonded best of all to Peptone, and
cure was certain in almost every such case.
3. That the shorter the duration of the Asthma the
more likelihood of success there would be.
4. Another point not referred to already - where
the family history of Asthma was marked the more
difficult was it to cure by Peptone.
5. Intramuscular injections of Armour's Peptone gave
better permanent results than the intravenous
Witte's Peptone, although the latter in certain
cases was extremely successful after a single
intravenous injection.
6. "Protein Shock" when severe usually benefited
cases of Asthma little, especially when the
patients were sensitive to foreign proteins.
On/
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On the other hand a slight degree of "protein
shock" was necessary in long standing cases of
asthma and in those which did not yield to the
first few doses of Peptone.
RESULTS IN RHEUMATOID ARTHRITIS.
1. That where the Rheumatoid Arthritis was poly¬
articular not all of the affected joints bene¬
fited to the same extent - with the exception of
those two cases of cure mentioned. Some of the
joints showed marked improvement, while at least
one or more were only slightly benefited.
S. The maximum number of injections given was 8
intramuscular 1.5 gms. of Armour1s Peptone being
reached.
3. The sharper the General Reaction and consequently
the more intense the Focal, the better the clin¬
ical result.
4. Some authorities state that unless a sharp re¬
action is elicited at the first injection subse¬
quent injections will as a rule be followed by





studied the reaction did not usually follow until
the 4th or 5th injection, and the results were
fairly satisfactory.
0
Where definite bony changes or ankylosis had
occurred Peptone Therapy met with little or no
success. The longer the duration of the disease
the less likelihood was there of success.
The tendency to immediate recurrence was not great
Most of the cases were seen 2-3 months later.
Two cases were seen 8 months later - who had
benefited with treatment - and there had been no
recurrence. In those cases where recurrence had
taken place, "protein shock" when again induced
had little or no beneficial effects.
PEPTONE-THERAPY











50$-60$ 20$ - 20$
Arthritis. g$-iO$; 25$-30$ 40$-50$ 15$-18$
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Prom these results there can be no doubt that Peptone
Is of more value in Asthma than in Rheumatoid Arthritiji
In Asthma about half of the cases were cured and free
from attacks. The percentage of cure in Rheumatoid
Arthritis was small. If these cases of Arthritis hac
been treated earlier, then the percentage of cure
would certainly have been higher. It was just as in
Asthma, the more marked the secondary changes the less
chance was there of success.
Another point observed - that Asthma was either
cured or greatly improved with Peptone, or else it was
not improved at all. In Rheumatoid Arthritis although
the cases cured were few, a large percentage was
markedly improved or slightly improved. The percent¬
age of "no improvement" was smaller than in Asthma.
There was a greater tendency for recurrence after
treatment in cases of Asthma than in cases of Rheu¬
matoid Arthritis.
In Asthma - 20$ - 25%
In Rheumatoid Arthritis 12$ - 15$
2. Actions compared.
In Rheumatoid Arthritis one endeavoured to
produce a definite "Protein Shock", whereas in Asthma
it was avoided if possible and only in resistant cases
was/
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waa a mild reaction induced. Many authorities advocate
the same type of reaction in both diseases, but as has
been seen in the cases of Asthma - and in accordance
with the views of other authorities - a violent
"protein shock" benefited the cases little and recur¬
rences were more apt to occur.
We have seen that a process of neutralisation or
desensitisation occurred in "Protein Shock" and also
that a process of desensitisation occurred in asthma¬
tics treated with Peptone. Some definitely state that
in Asthma it is a process of desensitisation and in
Rheumatoid Arthritis it is one of "Protein Shock", in
other words asserting that "Protein Shock" is not a
process of desensitisation in any way related to that
occurring in Asthma.
Supposing we accept the two possible theories
already put forward in Asthma and Rheumatoid Arthritis
respectively and compare them. In Asthma it was
said that an "adzyme" was present in the blood of an
individual sensitive to a foreign protein. What the
chemical nature of this adzyme is, no one can say.
In Rheumatoid Arthritis there were supposed to be
split-protein poisons circulating in the blood which
were the result of bacterial infection. When an in¬
jection of Peptone was given in Asthma, it interacted
with/
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with the adzyme desensitising it, and in Rheumatoid
Arthritis it interacted with the split-protein poisons
desensitising them. The interaction might produce
"Protein Shock", or it might not, depending on certair
factors. When "Protein Shock" was produced in
Rheumatoid Arthritis" the maximum point of desensitise
tion seemed to be reached, whereas in Asthma this
point might be reached - with cure - without "Protein
Shock" being induced. Thus it would appear that the
action of Peptone in the two diseases is closely re¬
lated, and the principle of the mechanism is more or
less the same in both.
In both diseases the best results occurred when
Peptone was used early in the disease. Prom the studjj'
of these cases it will be seen that Peptone Therapy
offers a very important and successful therapeutic
measure in two conditions which have been so resistan
to all kinds of former treatment. This new treatment
is still in its infancy, and requires judgment, and
careful attention on the part of the physician. The
great disadvantage of its use at present is the great
discomfort and anxiety it may cause the patient
especially in these cases of "Protein Shock". It Is
hoped, that in future some non-specific protein be
discovered/
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discovered that will give the same therapeutic effect
without the severe reaction. As yet no such sub¬
stance has been found.
